Literature DB >> 20192967

Biosynthesis of uronamide sugars in Pseudomonas aeruginosa O6 and Escherichia coli O121 O antigens.

Jerry D King1, Evgeny Vinogradov, Vanessa Tran, Joseph S Lam.   

Abstract

The major component of the outer leaflet of the outer membrane of Gram-negative bacteria is lipopolysaccharide (LPS). The outermost domain of LPS is a polysaccharide called O antigen. Pseudomonas aeruginosa establishes biofilms on wet surfaces in a wide range of habitats and mutations in O-antigen biosynthesis genes affect bacterial adhesion and the structure of these biofilms. The P. aeruginosa O6 O antigen contains a 2-acetamido-2-deoxy-d-galacturonamide (d-GalNAcAN) residue. O-antigen biosynthesis in this serotype requires the wbpS gene, which encodes a protein with conserved domains of the glutamine-dependent amidotransferase family. Replacement of conserved amino acids in the N-terminal glutaminase conserved domain of WbpS inhibited O-antigen biosynthesis under restricted-ammonia conditions, but not in rich media; suggesting that this domain functions to provide ammonia for O-antigen biosynthesis under restricted-ammonia conditions, by hydrolysis of glutamine. Escherichia coli O121 also produces a d-GalNAcAN-containing O antigen, and possesses a homologue of wbpS called wbqG. An E. coli O121 wbqG mutant was cross-complemented by providing wbpS in trans, and vice versa, showing that these two genes are functionally interchangeable. The E. coli O121 wbqG mutant O antigen contains 2-acetamido-2-deoxy-d-galacturonate (d-GalNAcA), instead of d-GalNAcAN, demonstrating that wbqG is specifically required for biosynthesis of the carboxamide in this sugar.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192967     DOI: 10.1111/j.1462-2920.2010.02182.x

Source DB:  PubMed          Journal:  Environ Microbiol        ISSN: 1462-2912            Impact factor:   5.491


  7 in total

1.  Identification of genes involved in the acetamidino group modification of the flagellin N-linked glycan of Methanococcus maripaludis.

Authors:  Gareth M Jones; John Wu; Yan Ding; Kaoru Uchida; Shin-Ichi Aizawa; Anna Robotham; Susan M Logan; John Kelly; Ken F Jarrell
Journal:  J Bacteriol       Date:  2012-03-09       Impact factor: 3.490

2.  Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.

Authors:  Michael Wetter; Michael Kowarik; Michael Steffen; Paula Carranza; Giampietro Corradin; Michael Wacker
Journal:  Glycoconj J       Date:  2012-10-06       Impact factor: 2.916

3.  Characterization of the structurally diverse N-linked glycans of Campylobacter species.

Authors:  Adrian J Jervis; Jonathan A Butler; Andrew J Lawson; Rebecca Langdon; Brendan W Wren; Dennis Linton
Journal:  J Bacteriol       Date:  2012-03-02       Impact factor: 3.490

4.  Genetic and Functional Diversity of Pseudomonas aeruginosa Lipopolysaccharide.

Authors:  Joseph S Lam; Véronique L Taylor; Salim T Islam; Youai Hao; Dana Kocíncová
Journal:  Front Microbiol       Date:  2011-06-01       Impact factor: 5.640

5.  EmbRS a new two-component system that inhibits biofilm formation and saves Rubrivivax gelatinosus from sinking.

Authors:  Anne Soisig Steunou; Sylviane Liotenberg; Marie-Noêlle Soler; Romain Briandet; Valérie Barbe; Chantal Astier; Soufian Ouchane
Journal:  Microbiologyopen       Date:  2013-03-21       Impact factor: 3.139

6.  Functional analysis of the Helicobacter pullorum N-linked protein glycosylation system.

Authors:  Adrian J Jervis; Alison G Wood; Joel A Cain; Jonathan A Butler; Helen Frost; Elizabeth Lord; Rebecca Langdon; Stuart J Cordwell; Brendan W Wren; Dennis Linton
Journal:  Glycobiology       Date:  2018-04-01       Impact factor: 4.313

7.  Type IX Secretion System Cargo Proteins Are Glycosylated at the C Terminus with a Novel Linking Sugar of the Wbp/Vim Pathway.

Authors:  Paul D Veith; Mikio Shoji; Richard A J O'Hair; Michael G Leeming; Shuai Nie; Michelle D Glew; Gavin E Reid; Koji Nakayama; Eric C Reynolds
Journal:  mBio       Date:  2020-09-01       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.